Zelira Therapeutics Limited ZLDAF

Set alert

Price alert · ZLDAF

All alert types
0.21 USD 0.00 0.00%

At close · Oct 29

0.01 Day range 0.01
0.01 52-week range 0.4165
YTD
-24.52%
1 year
-7.78%
Open
0.01
Prev close
0.205
Mkt cap
2.70M
Vol
200
Avg vol
8
EPS
-0.20
P/E
0.00
More statistics
Low
0.01
High
0.01

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ZLDAF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-106.60 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.3×
FY 2016: -6.8×FY 2017: -5.7×FY 2018: -42.5×FY 2019: -10.2×FY 2020: -7.5×FY 2021: -6.5×FY 2022: -0.7×FY 2023: -2.7×FY 2024: -0.1×FY 2025: -1.3×
FY 2016 5y median -1.3× FY 2025
P/S 7426×
FY 2016: 20.3×FY 2017: 354×FY 2018: 234×FY 2019: 47.4×FY 2020: 0.0×FY 2021: 84.0×FY 2022: 5.2×FY 2023: 49.2×FY 2024: 41.8×FY 2025: 7426×
FY 2016 5y median 49.2× FY 2025
P/B -1.1×
FY 2016: -30.0×FY 2017: 4.5×FY 2018: 11.8×FY 2019: 11.7×FY 2020: 1.5×FY 2021: 1.5×FY 2022: 0.2×FY 2023: 0.5×FY 2024: -0.9×FY 2025: -1.1×
FY 2016 5y median 0.2× FY 2025
P/FCF -1.0×
FY 2016: -18.3×FY 2017: -16.0×FY 2018: -28.0×FY 2019: -10.8×FY 2020: -7.6×FY 2021: -6.5×FY 2022: -0.8×FY 2023: -2.0×FY 2024: -0.9×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -1.7×
FY 2016: -9.5×FY 2017: -7.2×FY 2018: 211×FY 2019: -32.7×FY 2020: -6.7×FY 2021: -6.4×FY 2022: -0.5×FY 2023: -2.3×FY 2024: -0.3×FY 2025: -1.7×
FY 2016 5y median -1.7× FY 2025
EV/Sales 10682×
FY 2016: 23.4×FY 2017: 275×FY 2018: 216×FY 2019: 43.4×FY 2020: 0.0×FY 2021: 77.3×FY 2022: 3.7×FY 2023: 50.1×FY 2024: 98.2×FY 2025: 10682×
FY 2016 5y median 77.3× FY 2025
FCF Yield -100.7%
FY 2016: -5.5%FY 2017: -6.2%FY 2018: -3.6%FY 2019: -9.3%FY 2020: -13.1%FY 2021: -15.5%FY 2022: -118.3%FY 2023: -49.0%FY 2024: -110.7%FY 2025: -100.7%
FY 2016 5y median -100.7% FY 2025

Profitability

Gross Margin -122400.2%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: -5.9%FY 2022: -371.0%FY 2023: -1068.0%FY 2024: 10.8%FY 2025: -122400.2%
FY 2016 5y median -371.0% FY 2025
Operating Margin -602467.8%
FY 2016: -292.1%FY 2017: -2569.3%FY 2018: -897.4%FY 2019: -549.7%FY 2020: 0.0%FY 2021: -1455.1%FY 2022: -870.7%FY 2023: -2159.3%FY 2024: -6253.9%FY 2025: -602467.8%
FY 2016 5y median -2159.3% FY 2025
Net Margin -553029.3%
FY 2016: -299.5%FY 2017: -6154.8%FY 2018: -551.3%FY 2019: -463.9%FY 2020: 0.0%FY 2021: -1288.8%FY 2022: -775.4%FY 2023: -1850.8%FY 2024: -38513.0%FY 2025: -553029.3%
FY 2016 5y median -1850.8% FY 2025
ROE 81.3%
FY 2016: 442.9%FY 2017: -78.0%FY 2018: -27.8%FY 2019: -114.8%FY 2020: -20.3%FY 2021: -22.6%FY 2022: -33.9%FY 2023: -17.5%FY 2024: 810.0%FY 2025: 81.3%
FY 2016 5y median -17.5% FY 2025
ROIC 183.9%
FY 2016: 353.2%FY 2017: -32.0%FY 2018: -38.4%FY 2019: -111.9%FY 2020: -19.5%FY 2021: -21.7%FY 2022: -33.6%FY 2023: -20.2%FY 2024: -326.2%FY 2025: 183.9%
FY 2016 5y median -21.7% FY 2025
ROA -278.9%
FY 2016: -1026.8%FY 2017: -77.3%FY 2018: -27.4%FY 2019: -101.5%FY 2020: -19.6%FY 2021: -21.7%FY 2022: -31.7%FY 2023: -16.4%FY 2024: -705.5%FY 2025: -278.9%
FY 2016 5y median -31.7% FY 2025

Growth (YoY)

Revenue -99.3%
FY 2016: 0.0%FY 2017: -66.7%FY 2018: 213.6%FY 2019: 145.1%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 132.3%FY 2023: -80.5%FY 2024: -68.5%FY 2025: -99.3%
FY 2016 FY 2025
Operating Income 33.4%
FY 2016: -106.8%FY 2017: -193.3%FY 2018: -9.5%FY 2019: -50.1%FY 2020: -85.4%FY 2021: -23.1%FY 2022: -39.0%FY 2023: 51.5%FY 2024: 8.7%FY 2025: 33.4%
FY 2016 FY 2025
EPS (diluted) 90.1%
FY 2016: -90.4%FY 2017: -56.8%FY 2018: 81.7%FY 2019: -107.5%FY 2020: -74.7%FY 2021: 11.0%FY 2022: -15.5%FY 2023: 63.1%FY 2024: -485.5%FY 2025: 90.1%
FY 2016 FY 2025
Free Cash Flow -11.8%
FY 2016: -13.3%FY 2017: -565.5%FY 2018: -18.9%FY 2019: -28.5%FY 2020: -106.1%FY 2021: -23.9%FY 2022: -9.4%FY 2023: 23.1%FY 2024: 39.5%FY 2025: -11.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 0.3×FY 2017: 113×FY 2018: 58.1×FY 2019: 7.7×FY 2020: 2.7×FY 2021: 5.7×FY 2022: 3.1×FY 2023: 0.9×FY 2024: 0.6×FY 2025: 0.1×
FY 2016 5y median 0.9× FY 2025
Quick Ratio 0.0×
FY 2016: 0.4×FY 2017: 114×FY 2018: 58.8×FY 2019: 7.8×FY 2020: 2.7×FY 2021: 4.9×FY 2022: 1.9×FY 2023: 0.1×FY 2024: 0.4×FY 2025: 0.0×
FY 2016 5y median 0.4× FY 2025
Debt / Equity -0.5×
FY 2016: -4.9×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -1.3×FY 2025: -0.5×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.5×
FY 2016: -1.3×FY 2017: 2.1×FY 2018: -17.7×FY 2019: 3.0×FY 2020: 0.1×FY 2021: 0.5×FY 2022: 0.2×FY 2023: -0.0×FY 2024: -0.2×FY 2025: -0.5×
FY 2016 5y median -0.0× FY 2025
Interest Coverage -9.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -635×FY 2021: -226×FY 2022: -249×FY 2023: -84.8×FY 2024: -8.0×FY 2025: -9.7×
FY 2016 5y median -84.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 24.2%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -139.4%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-06-30